These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16918905)

  • 1. Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.
    Huang Y; Liu D; Wu H
    Biometrics; 2006 Jun; 62(2):413-23. PubMed ID: 16918905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical methods for HIV dynamic studies in AIDS clinical trials.
    Wu H
    Stat Methods Med Res; 2005 Apr; 14(2):171-92. PubMed ID: 15807150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients.
    Labbé L; Verotta D
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):519-42. PubMed ID: 16786410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.
    Wu H; Huang Y; Acosta EP; Rosenkranz SL; Kuritzkes DR; Eron JJ; Perelson AS; Gerber JG
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):272-83. PubMed ID: 15980686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors.
    Huang Y; Wu H; Acosta EP
    Biom J; 2010 Aug; 52(4):470-86. PubMed ID: 20661953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameter identifiability and estimation of HIV/AIDS dynamic models.
    Wu H; Zhu H; Miao H; Perelson AS
    Bull Math Biol; 2008 Apr; 70(3):785-99. PubMed ID: 18247096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.
    Wu H; Huang Y; Acosta EP; Park JG; Yu S; Rosenkranz SL; Kuritzkes DR; Eron JJ; Perelson AS; Gerber JG
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):399-419. PubMed ID: 16583266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.
    Huang Y; Dagne G; Wu L
    Stat Med; 2011 Oct; 30(24):2930-46. PubMed ID: 21805486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed-effects state-space models for analysis of longitudinal dynamic systems.
    Liu D; Lu T; Niu XF; Wu H
    Biometrics; 2011 Jun; 67(2):476-85. PubMed ID: 20825393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian estimation of HIV-1 dynamics in vivo.
    Ushakova A; Pettersen FO; Mæland A; Lindqvist BH; Kvale D
    Math Med Biol; 2015 Mar; 32(1):38-55. PubMed ID: 24078026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian Experimental Design for Long-Term Longitudinal HIV Dynamic Studies.
    Huang Y; Wu H
    J Stat Plan Inference; 2008 Jan; 138(1):105-113. PubMed ID: 22135475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchical mixture models for longitudinal immunologic data with heterogeneity, non-normality, and missingness.
    Huang Y; Chen J; Yin P
    Stat Methods Med Res; 2017 Feb; 26(1):223-247. PubMed ID: 25038070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piecewise mixed-effects models with skew distributions for evaluating viral load changes: A Bayesian approach.
    Huang Y; Dagne GA; Zhou S; Wang Z
    Stat Methods Med Res; 2015 Dec; 24(6):730-46. PubMed ID: 22045781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics.
    Luo R; Piovoso MJ; Martinez-Picado J; Zurakowski R
    PLoS One; 2012; 7(7):e40198. PubMed ID: 22815727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian Approach in Differential Equation Dynamic Models Incorporating Clinical Factors and Covariates.
    Huang Y
    J Appl Stat; 2010 Feb; 37(2):181-199. PubMed ID: 20445811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of HIV dynamic parameters.
    Wu H; Ding AA; De Gruttola V
    Stat Med; 1998 Nov; 17(21):2463-85. PubMed ID: 9819839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum likelihood estimation of long-term HIV dynamic models and antiviral response.
    Lavielle M; Samson A; Karina Fermin A; Mentré F
    Biometrics; 2011 Mar; 67(1):250-9. PubMed ID: 20486926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of human immunodeficiency virus type 1 coreceptor usage during antiretroviral Therapy: a Bayesian approach.
    Kitchen CM; Philpott S; Burger H; Weiser B; Anastos K; Suchard MA
    J Virol; 2004 Oct; 78(20):11296-302. PubMed ID: 15452249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.